<SEC-DOCUMENT>0001193125-16-514197.txt : 20160323
<SEC-HEADER>0001193125-16-514197.hdr.sgml : 20160323
<ACCEPTANCE-DATETIME>20160323082036
ACCESSION NUMBER:		0001193125-16-514197
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160323
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160323
DATE AS OF CHANGE:		20160323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORASURE TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0001116463
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				364370966
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16537
		FILM NUMBER:		161522527

	BUSINESS ADDRESS:	
		STREET 1:		150 WEBSTER ST
		CITY:			BETHLEHEM
		STATE:			PA
		ZIP:			18015
		BUSINESS PHONE:		5036416115

	MAIL ADDRESS:	
		STREET 1:		150 WEBSTER ST
		CITY:			BETHLEHEM
		STATE:			PA
		ZIP:			18015
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d127345d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT
TO SECTION 13 OR 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported):&nbsp;March 23, 2016 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>OraSure Technologies, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>001-16537</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>36-4370966</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of Incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>220 East First Street</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Bethlehem, Pennsylvania</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>18015-1360</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of Principal Executive Offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: 610-882-1820 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the
following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5.02 &#150; Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>New Director Appointment </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March 22, 2016, Eamonn P. Hobbs was appointed as a new member of the Board of Directors (the &#147;Board&#148;) of OraSure Technologies, Inc. (the
&#147;Company&#148;). Mr. Hobbs will serve as a Class I Director with an initial term expiring at the Company&#146;s 2016 Annual Meeting of Stockholders. Mr. Hobbs has also been appointed to serve on the Board&#146;s Audit Committee and Compensation
Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Company&#146;s Non-Employee Director Compensation Policy (the &#147;Policy&#148;) and Stock Award Plan, Mr. Hobbs was granted
an option to purchase 40,000 shares of the Company&#146;s common stock with an exercise price equal to the mean between the high and low sales prices of the Company&#146;s common stock on the date of his appointment. The foregoing option will vest
on a monthly basis over the 24-month period following the grant date. Vesting will be accelerated in the event of a change in control involving the Company. Mr. Hobbs will also receive fees and additional equity compensation pursuant to the Policy.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A press release announcing Mr. Hobbs&#146; appointment to the Board is attached as Exhibit 99.1 to this Report and is incorporated by reference herein.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item 9.01 &#150; financial Statements and Exhibits. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d) Exhibits </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:26.20pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Number</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release dated March 23, 2016 announcing the appointment of Eamonn P. Hobbs as a member of the Company&#146;s Board of Directors</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Signatures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B><I></I></B>O<SMALL>RA</SMALL>S<SMALL>URE</SMALL> T<SMALL>ECHNOLOGIES</SMALL>, I<SMALL>NC</SMALL>.<B><I></I></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: March&nbsp;23, 2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Jack E. Jerrett</I></P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Jack E. Jerrett</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, General Counsel and Secretary</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Index to Exhibits </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:26.20pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Number</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release dated March 23, 2016 announcing the appointment of Eamonn P. Hobbs as a member of the Company&#146;s Board of Directors</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d127345dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g127345g0322044548073.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Contact: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ronald H.
Spair </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Financial Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(610) 882-1820 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>investorinfo@orasure.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OraSure
Technologies Appoints Eamonn P. Hobbs to its Board of Directors </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BETHLEHEM, PA</B>. &#150; March 23, 2016 &#150; OraSure Technologies, Inc.
(NASDAQ: OSUR), today announced the appointment of Mr. Eamonn P. Hobbs as a member of the Company&#146;s Board of Directors. Mr. Hobbs will serve as a Class I Director with an initial term expiring at the Company&#146;s 2016 Annual Meeting of
Stockholders. He will also serve on the Company&#146;s Audit and Compensation Committees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are delighted to welcome Eamonn Hobbs as a new member
of our Board of Directors,&#148; said Douglas G. Watson, Chairman of the Board of OraSure Technologies.&nbsp;&#147;Eamonn&#146;s executive leadership, board experience and extensive background in the medical device industry, make him an excellent
addition to our Board.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr. Hobbs has over 30 years of experience in the medical device industry including the specialty fields of interventional
radiology, vascular surgery, interventional cardiology, surgical oncology, and gastroenterology. He most recently served as President and Chief Executive Officer at Antares Pharma, Inc. (NASDAQ: ATRS), a small cap pharmaceutical company based in
Ewing, N.J.&nbsp;Previously, he served as President and Chief Executive Officer at Delcath Systems Inc., a specialty pharmaceutical and medical device company focused on oncology. Hobbs also served on the Board of Directors of both Antares Pharma
and Delcath Systems. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to Delcath, Mr. Hobbs co-founded AngioDynamics, Inc. in 1988 and served as the Company&#146;s President and Chief Executive
Officer until 2008. During his tenure there, he built the Company into a global market leader with more than $200 million in revenues and 700 employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr. Hobbs served as Chairman of the Board of Directors of the Medical Device Manufacturers Association from 2010 to 2013. He currently is Chairman of the
Board of Marvao Medical, Inc., a medical technology company based in Galway, Ireland and serves on the Board of Directors of Harmonic Medical, Inc., a development stage medical device company based in Toronto, Canada. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2006, Mr. Hobbs was granted an honorary fellowship in the Society of Interventional Radiology, which was only the third honorary fellowship ever granted a
non-physician in the Society&#146;s 40-year history. He received his Bachelor of Science in Plastics Engineering from the University of Massachusetts, and in 2010, he was honored by the University with the &#147;Francis Cabot Lowell Award for
Outstanding Achievement in Business.&#148; </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About OraSure Technologies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OraSure Technologies is a leader in the development, manufacture and distribution of point of care diagnostic and collection devices and other technologies
designed to detect or diagnose critical medical conditions. Its first-to-market, innovative products include rapid tests for the detection of antibodies to HIV and HCV on the OraQuick<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>
platform, oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications, and oral fluid laboratory tests for detecting various drugs of abuse. OraSure&#146;s portfolio of products is sold globally to
various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians&#146; offices, commercial and industrial
entities and consumers. The Company&#146;s products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information on OraSure Technologies, please visit <U>www.orasure.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"># # # </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g127345g0322044548073.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g127345g0322044548073.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !( 2(# 2(  A$! Q$!_\0
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8@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
